Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Revenue: 2017-2025

Historic Revenue for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to $26.0 million.

  • Arcus Biosciences' Revenue fell 45.83% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.0 million, marking a year-over-year decrease of 8.75%. This contributed to the annual value of $258.0 million for FY2024, which is 120.51% up from last year.
  • Per Arcus Biosciences' latest filing, its Revenue stood at $26.0 million for Q3 2025, which was down 83.75% from $160.0 million recorded in Q2 2025.
  • Arcus Biosciences' Revenue's 5-year high stood at $354.6 million during Q4 2021, with a 5-year trough of $9.5 million in Q1 2021.
  • Moreover, its 3-year median value for Revenue was $31.0 million (2023), whereas its average is $53.5 million.
  • Per our database at Business Quant, Arcus Biosciences' Revenue spiked by 3,637.93% in 2021 and then plummeted by 90.41% in 2022.
  • Arcus Biosciences' Revenue (Quarterly) stood at $354.6 million in 2021, then slumped by 90.41% to $34.0 million in 2022, then dropped by 8.82% to $31.0 million in 2023, then fell by 16.13% to $26.0 million in 2024, then crashed by 45.83% to $26.0 million in 2025.
  • Its Revenue stands at $26.0 million for Q3 2025, versus $160.0 million for Q2 2025 and $28.0 million for Q1 2025.